0000950170-24-035358.txt : 20240322
0000950170-24-035358.hdr.sgml : 20240322
20240322161223
ACCESSION NUMBER: 0000950170-24-035358
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240320
FILED AS OF DATE: 20240322
DATE AS OF CHANGE: 20240322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RIGGS RORY B
CENTRAL INDEX KEY: 0001016835
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36274
FILM NUMBER: 24775339
MAIL ADDRESS:
STREET 1: 65 RAILROAD AVE
CITY: RIDGEFIELD
STATE: NJ
ZIP: 07657
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc.
CENTRAL INDEX KEY: 0001567514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 364742850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 212-923-3344
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Oneida Resources Corp.
DATE OF NAME CHANGE: 20130122
4
1
ownership.xml
4
X0508
4
2024-03-20
0001567514
Intra-Cellular Therapies, Inc.
ITCI
0001016835
RIGGS RORY B
C/O INTRA-CELLULAR THERAPIES, INC.
430 EAST 29TH STREET
NEW YORK
NY
10016
true
false
false
false
false
Common Stock
2024-03-20
4
M
false
20000
18.56
A
99235
D
Stock Option (right to buy)
18.56
2024-03-20
4
M
false
20000
0
D
2024-03-21
Common Stock
20000
0
D
On March 20, 2024, the reporting person exercised options to purchase 20,000 shares of common stock that were expiring on March 21, 2024.
On March 21, 2014, the reporting person was granted options to purchase 20,000 shares of common stock, vesting as to 50% of the shares on January 8, 2015 and as to the remainder of the shares on January 8, 2016.
/s/ Lawrence J. Hineline, Attorney-in-fact
2024-03-22